Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Andrew Dudum, CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold a significant portion of his holdings in the company.

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Hims & Hers Health Inc. (NYSE: HIMS), a telehealth company with a $6.1 billion valuation, has been a remarkable growth story, ...

Donald Trump's first inauguration in 2017 reportedly was estimated to cost as much as $200 million. Here's who pays the ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.94 which represents a slight increase of $0.08 or 0.29% from the prior close of $27.86. The stock opened at $28.09 and ...

Hims & Hers (HIMS) is down -6.5%, or -$1.81 to $26.13.Stay Ahead of the Market:Discover outperforming stocks and invest smarter with Top ...

In a report released today, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers Health (HIMS – Research ...

A new Washington means new communication opportunities and risks for those in the health care and pharmaceutical space.